Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
<p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks)...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Övriga upphovsmän: | , , , , , , , , , , , , , , , , , |
| Publicerad: |
2025
|
| Ämnen: | |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
| _version_ | 1849927632870703104 |
|---|---|
| author | Abdullah A. Osman (15056323) |
| author2 | Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author2_role | author author author author author author author author author author author author author author author author author author |
| author_facet | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author_role | author |
| dc.creator.none.fl_str_mv | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| dc.date.none.fl_str_mv | 2025-11-25T13:12:03Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708156 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S5_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708156 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| dc.title.none.fl_str_mv | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks) gained in cisplatin-resistant HN30-R8 cells following CDDP treatment.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_9d7ae110429c0f8ed41c5d2a14e4f069 |
| identifier_str_mv | 10.1158/1078-0432.30708156 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708156 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell CarcinomaAbdullah A. Osman (15056323)Emre Arslan (15056326)Mason Bartels (15056329)Chieko Michikawa (15056332)Antje Lindemann (15056335)Katarzyna Tomczak (15056338)Wangjie Yu (15056341)Vlad Sandulache (15056344)Wencai Ma (15056347)Li Shen (14959241)Jing Wang (14959256)Anand K. Singh (15056350)Mitchell J. Frederick (14959253)Nakia D. Spencer (15056353)Jeffery Kovacs (15056356)Timothy Heffernan (15056359)William F. Symmans (15056362)Kunal Rai (15056365)Jeffrey N. Myers (15026901)CancerCancer Risk FactorsTumor BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyDrug ResistanceDrug TargetsEpigeneticsEpigenomicsHead, Neck & Oral CancersPreclinical ModelsProgression, Invasion & MetastasisTumor progressionSmall Molecule Agents<p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks) gained in cisplatin-resistant HN30-R8 cells following CDDP treatment.</p>2025-11-25T13:12:03ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708156https://figshare.com/articles/dataset/Supplementary_Table_S5_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708156CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307081562025-11-25T13:12:03Z |
| spellingShingle | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma Abdullah A. Osman (15056323) Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| status_str | publishedVersion |
| title | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_fullStr | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full_unstemmed | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_short | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_sort | Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| topic | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |